Kelly Koehn

Director of Clinical Operations at Cingulate Therapeutics - Roeland Park, KS, US

Kelly Koehn's Colleagues at Cingulate Therapeutics
Laurie Myers

Chief Operating Officer

Contact Laurie Myers

Arthur Straughn

Co-founder Board of Directors

Contact Arthur Straughn

Lou Van Horn

Chief Financial Officer

Contact Lou Van Horn

Holly Mitzel

Vice President of Clinical Operations and Regulatory Affairs

Contact Holly Mitzel

View All Kelly Koehn's Colleagues
Kelly Koehn's Contact Details
HQ
913-942-2300
Location
Mission,Kansas,United States
Company
Cingulate Therapeutics
Kelly Koehn's Company Details
Cingulate Therapeutics logo, Cingulate Therapeutics contact details

Cingulate Therapeutics

Roeland Park, KS, US • 20 - 49 Employees
Major Drugs

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.

N/A
Details about Cingulate Therapeutics
Frequently Asked Questions about Kelly Koehn
Kelly Koehn currently works for Cingulate Inc..
Kelly Koehn's role at Cingulate Inc. is Director of Clinical Operations.
Kelly Koehn's email address is ***@cingulate.com. To view Kelly Koehn's full email address, please signup to ConnectPlex.
Kelly Koehn works in the Pharmaceuticals industry.
Kelly Koehn's colleagues at Cingulate Therapeutics are Carla Soptic, Laurie Myers, Arthur Straughn, Craig Gilgallon, Lou Van Horn, Holly Mitzel, Jennifer Callahan and others.
Kelly Koehn's phone number is 913-942-2300
See more information about Kelly Koehn